The results of Wang et al. [80] indicated strong association between overexpression of IL-8 in tumor tissue, serum, ovarian cyst fluid, and ascites from ovarian cancer patients and poor sensitivity for a variety of anticancer agents used during their chemotherapy. The gene discussed is CXCL8; the disease is ovarian carcinoma.